drugset / Trial / NCT02293564
Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term safety of gevokizumab in the treatment of active inflammatory, erosive osteoarthritis of the hand.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gevokizumab | Monoclonal antibody | — | Subcutaneous |